Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis

Inclusion Criteria:

• Diagnosis of non-infectious uveitis (pan, anterior, intermediate and posterior)
• Diagnosis of macular edema associated with non-infectious uveitis (retinal thickness ≥ 300 microns)
• Visual Acuity score of ≥ 5 letters read (20/800 Snellen equivalent) and ≤ 70 lettersread (20/40 Snellen equivalent), in the study eye

Exclusion Criteria:

• Any active ocular disease or infection in the study eye other than uveitis
• Intraocular pressure > 22 mmHg or uncontrolled glaucoma in the study eye; subjects arenot excluded if IOP ≤ 22 mmHg with no more than 2 IOP lowering medications.
• Any uncontrolled systemic disease that, in the opinion of the Investigator, wouldpreclude participation in the study
• Any topical ocular corticosteroid in the 10 days prior to baseline; intraocular orperiocular corticosteroid injections in the 2 months prior to baseline; an OZURDEXimplant in the 6 months prior to baseline; RETISERT or ILUVIEN implant in the 3 yearsprior to baseline.